Glecaprevir
ATC J05AP57 · 9 markets · 20 records
AU 5 records · 3 strengths
- 100 mgtabletMaviret 100mg/40mg tabletsMAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack、MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle
- 50 mgpowderMAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet
Records without a stated strength · 1 Maviret 100mg/40mg tablets
GB 4 records · 2 strengths
- 100 mgtabletMaviret 100mg/40mg tablets__no_trade__
- 50 mgpowderMaviret 50mg/20mg granules sachets__no_trade__
US 2 records · 2 strengths
CA 2 records · 2 strengths
- 100 mgtabletMaviret 100mg/40mg tablets
- 50 mgpowderMaviret 100mg/40mg tablets
ES 2 records · 2 strengths
- 40 mgtabletMaviret 100mg/40mg tablets
- 50 mgliquidMAVIRET GRANULOS
SG 1 records · 1 strengths
- 100 mgtabletMaviret 100mg/40mg tablets
TW 1 records · 1 strengths
Records without a stated strength · 1 Maviret 100mg/40mg tablets、艾百樂膜衣錠100毫克/40毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 Maviret 100mg/40mg tablets
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Maviret 100mg/40mg tablets
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 100 mg tablet | Mavyret | No trade name Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle | Maviret 100mg/40mg tablets | ||||
| 50 mg powder | No trade name Maviret 50mg/20mg granules sachets | Maviret 100mg/40mg tablets | MAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet | ||||||
| 40 mg tablet | Maviret 100mg/40mg tablets | ||||||||
| 50 mg liquid | MAVIRET GRANULOS | ||||||||
| 50 mg pellet | Mavyret | ||||||||
unknown | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | Maviret 100mg/40mg tablets | ||||||
tablet | Maviret 100mg/40mg tablets 艾百樂膜衣錠100毫克/40毫克 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in ES · TW and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en ES · TW que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 ES · TW 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 ES · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.